Published August 2019
| Version v1
Journal article
Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke — An Updated Comprehensive Meta-Analysis
Creators
- 1. Department of Internal Medicine, Division of Cardiology, East Tennessee State University, Johnson City, TN (United States)
- 2. Vanderbilt University Medical Center, Nashville, TN (United States)
- 3. Department of Medicine, Division of Cardiology, Texas Tech University Health Sciences Center, El Paso, TX (United States)
- 4. Winthrop University Hospital, New York (United States)
Description
The ideal treatment strategy for patients with cryptogenic stroke and patent foramen ovale (PFO) is not yet clear. Previous randomized controlled trials (RCTs) comparing transcatheter PFO closure with medical therapy in patients with cryptogenic stroke to prevent recurrent ischemic stroke showed mixed results. This meta-analysis aims to compare rates of recurrent stroke, transient ischemic attack (TIA) and all-cause mortality with PFO closure and medical therapy vs. medical therapy alone.
Additional details
Identifiers
- DOI
- 10.1016/j.carrev.2018.09.010;
- PII
- S1553838918304123;
Publishing Information
- Journal Title
- Cardiovascular Revascularization Medicine (Print)
- Journal Volume
- 20
- Journal Issue
- 8
- Journal Page Range
- p. 687-694
- ISSN
- 1553-8389
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55052381
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ISCHEMIA; MORTALITY; PATENTS; PATIENTS; THERAPY
- Descriptors DEC
- ANEMIAS; CARDIOVASCULAR DISEASES; DISEASES; DOCUMENT TYPES; HEMIC DISEASES; MEDICINE; SYMPTOMS; VASCULAR DISEASES
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.